1/2 tufccc/HC regional comprehensive cancer health disparity partnership

Active Cooperative Agreement Awarded Last action

Award ID
U54CA221705
Recipient
Awarding agency
Obligated
$27,389,546

Award facts

Assistance listing
93.397 Cancer Centers Support Grants
Completion date 82% complete
Originally
Funding
  • $25,764,915.00 Federal
  • $1,624,631.00 Non-federal
Place of performance
Philadelphia, PA 19140, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment TUFCCC/HC regional comprehensive cancer health partnership - the synergistic partnership for enhancing excellence in cancer health (SPEECH) is a highly… $1,670,747 $0
Amendment $1,552,139 $0
Amendment -$311,858 $0
Amendment $311,858 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment (1/2) tufccc/HC regional comprehensive cancer health disparities partnership $0 $0
Amendment Elucidating the roles of metabolic syndrome and non-alcoholic fatty liver disease among asian american patients with chronic hepatitis B $189,986 $0
Amendment $189,986 $0
Amendment $189,986 $0
Amendment $189,986 $0
Amendment (1/2) tufccc/HC regional comprehensive cancer health disparities partnership $1,763,950 $0
Amendment Elucidating the roles of metabolic syndrome and non-alcoholic fatty liver disease among asian american patients with chronic hepatitis B $1,763,950 $0
Amendment $1,763,950 $0
Amendment $1,763,950 $0
Amendment $1,763,950 $0
Amendment (1/2) tufccc/HC regional comprehensive cancer health disparities partnership $0 $0
Amendment Elucidating the roles of metabolic syndrome and non-alcoholic fatty liver disease among asian american patients with chronic hepatitis B $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment (1/2) tufccc/HC regional comprehensive cancer health disparities partnership $0 $0
Amendment $0 $0
Amendment (1/2) tufccc/HC regional comprehensive cancer health disparities partnership $0 $0
Amendment Elucidating the roles of metabolic syndrome and non-alcoholic fatty liver disease among asian american patients with chronic hepatitis B $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment (1/2) tufccc/HC regional comprehensive cancer health disparities partnership $0 $0
Amendment $1,591,989 $0
Amendment $1,591,989 $0
Amendment $1,591,989 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,624,631 $0
Amendment $1,624,631 $1,624,631
Amendment $0 $0
Amendment $0 $0
Amendment $1,657,271 $0
Amendment $1,608,811 $0
Original award $1,671,024 $0
Show all 48

Subawards

Subrecipient Amount Awarded
Fox Chase Cancer Center Phase 1 focuses on developing the intervention, training materials, fidelity procedures, and website through focus groups, stakeholder interviews, and regular… $616,717

Quick answers

Who received award U54CA221705?

U54CA221705 was awarded to Temple University-Of The Commonwealth System Of Higher Education by National Cancer Institute (National Institutes of Health) on September 19, 2018.

How much is award U54CA221705 worth?

$27,389,546 has been obligated on U54CA221705: $25,764,915 in federal funding and $1,624,631 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login